Affinia Therapeutics Presents New Preclinical Data on Novel AAV Capsids for Skeletal Muscle, Cardiac Muscle, and CNS at the American Society of Gene & Cell Therapy 26TH Annual Meeting

/PRNewswire/ -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV)...

Related Keywords

United States ,American ,Prnewswire Affinia ,Thomasm Edwards ,Bryan Mastis ,Los Angeles ,Charles Albright ,Critical Quality Attributes Through Process Development ,American Society Of Gene ,American Society ,Cell Therapy ,Annual Meeting ,Affinia Therapeutics ,Chief Scientific Officer ,Optimized Skeletal Muscle ,Cardiac Muscle ,West Hall ,Animal Model ,Oliver Gene ,Wednesday Poster ,Novel Adeno Associated Viral Vector Capsid ,Thursday Poster ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,